Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial.
Birsen Pınar YildizMesut BayraktarogluDidem Gorgun HattatogluKıvanç YükselPublished in: Clinical drug investigation (2019)
ClinicalTrials.gov Identifier NCT03028701.